Olema Oncology, Inc. (OLMA) stock
OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.22−0.14 (-1.90%)
Close on Nov 17, 2026Market cap $631.73MP/E –Yield –
Olema Oncology cash
Cash and short-term investments held at the end of each period.
Olema Oncology's cash was $461.10M at Jun 30, 2026. For fiscal 2025 it was $505.40M, up 16.4% from the year before. The highest annual figure on record is $505.40M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $505.40M | +16.4% |
| FY2024 | Dec 31, 2024 | $434.10M | +65.8% |
| FY2023 | Dec 31, 2023 | $261.80M | +28.1% |
| FY2022 | Dec 31, 2022 | $204.40M | -28.9% |
| FY2021 | Dec 31, 2021 | $287.30M | -15.1% |
| FY2020 | Dec 31, 2020 | $338.55M | +497766.2% |
| FY2019 | Dec 31, 2019 | $68.00K | -97.8% |
| FY2018 | Dec 31, 2018 | $3.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $461.10M | +27.4% |
| Q1 FY2026 | Mar 31, 2026 | $505.30M | +28.7% |
| Q4 FY2025 | Dec 31, 2025 | $505.40M | +16.4% |
| Q3 FY2025 | Sep 30, 2025 | $329.00M | +53.2% |
| Q2 FY2025 | Jun 30, 2025 | $361.90M | +51.4% |
| Q1 FY2025 | Mar 31, 2025 | $392.70M | +57.7% |
| Q4 FY2024 | Dec 31, 2024 | $434.10M | +65.8% |
| Q3 FY2024 | Sep 30, 2024 | $214.80M | -22.4% |
| Q2 FY2024 | Jun 30, 2024 | $239.10M | +42.8% |
| Q1 FY2024 | Mar 31, 2024 | $249.00M | +33.9% |
| Q4 FY2023 | Dec 31, 2023 | $261.80M | +28.1% |
| Q3 FY2023 | Sep 30, 2023 | $276.90M | +24.4% |
| Q2 FY2023 | Jun 30, 2023 | $167.40M | -30.5% |
| Q1 FY2023 | Mar 31, 2023 | $186.00M | -30.6% |
| Q4 FY2022 | Dec 31, 2022 | $204.40M | -28.9% |
| Q3 FY2022 | Sep 30, 2022 | $222.60M | -27.3% |
| Q2 FY2022 | Jun 30, 2022 | $240.70M | -24.3% |
| Q1 FY2022 | Mar 31, 2022 | $267.90M | -18.1% |
| Q4 FY2021 | Dec 31, 2021 | $287.30M | -15.1% |
| Q3 FY2021 | Sep 30, 2021 | $306.00M | +139.4% |
| Q2 FY2021 | Jun 30, 2021 | $318.10M | +530.2% |
| Q1 FY2021 | Mar 31, 2021 | $327.00M | +1071.7% |
| Q4 FY2020 | Dec 31, 2020 | $338.55M | +497766.2% |
| Q3 FY2020 | Sep 30, 2020 | $127.82M | +3959.2% |
| Q2 FY2020 | Jun 30, 2020 | $50.48M | – |
| Q1 FY2020 | Mar 31, 2020 | $27.91M | – |
| Q4 FY2019 | Dec 31, 2019 | $68.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $3.15M | – |
See a number that looks wrong?